The treatment that may block suicidal thoughts: New drug combination raises hope in severe depression
A new clinical study found that a combination of a single ketamine infusion with a short course of low-dose buprenorphine reduced suicidal thoughts in patients with major depression
Assessment
A clinical trial suggests that a single ketamine infusion paired with low-dose buprenorphine may reduce suicidal ideation in major depression patients. The finding matters because current pharmacological options for acute suicidal crisis remain limited. Next questions concern the durability of the effect and whether the combination carries addiction risk given buprenorphine's opioid profile.